The latest "European Dietary Guidelines for Diabetes Prevention" has been released! Losing 15% of weight is good for diabetes relief
Time of Update: 2022-10-03
Medical pulse through the collation of reports, please do not reprint without permission. On September 19, 2022, the 58th Annual Conference of the European Association for the Study of Diabetes (EASD)
2022 Breast Cancer Summer Forum·Northern Salon｜Professor Wang Xiaojia explains the application of CDK4/6 inhibitors in breast cancer patients
Time of Update: 2022-08-20
"2022 Breast Cancer Summer Forum·Northern Salon" will be held in Beijing on July 30, 2022 . The conference invites experts and scholars to share the latest progress in breast cancer surgery and medica
Neurology: The impact of the COVID-19 pandemic on the practice of epilepsy centers in the United States
Time of Update: 2022-04-24
Conclusions: Access to care for people with epilepsy declined during the 2020 COVID-19 pandemic in the United States .
In the United States, access to care for people with epilepsy declined during the 2020 COVID-19 pandemic .
How to make early diagnosis and treatment when encountering a comatose patient
Time of Update: 2021-11-05
(2) Grading evaluation is based on a study published in the Chinese Journal of Neurology in 2005: 44 patients were enrolled, SLSEP and SLAEP were combined, and the results showed that: the sensitivity and sensitivity of predicting poor prognosis The specificity is improved, suggesting that multi-mode is better than single-mode .
J Clin Oncol: Effect of Veliparib combined with carboplatin + paclitaxel chemotherapy as the first-line treatment of advanced lung squamous cell carcinoma
Time of Update: 2021-09-11
OS and PFS in all patientsOS and PFS in all patientsIn the general population, compared with the placebo group, patients in the Veliparib group achieved OS benefits, with a median OS of 12.
[Phase 3] Standardized Diagnosis and Treatment Courses for Prostate Cancer——Progress in Research on Prostate Cancer Surgery
Time of Update: 2021-03-24
The third phase of "Prostate Cancer Standardized Diagnosis and Treatment Course" The third phase is "Prostate Cancer Surgery Research Progress" brought by Professor Chen Wei from the First Affiliated Hospital of Wenzhou Medical University: Click to watch the highlights video!
"Pharmaceutical Rapid Reading Society" IL-6R antibody new crown phase III clinical failure 4 innovative drugs approved in China
Time of Update: 2020-08-27
July 30, 2020 / Pharmaceutical Information List: Roche IL-6R Antibody New Crown Phase III Clinical Failure; Vantage Bio and Sanofi Reach Rotavirus Vaccine Licensing License Deal; AbbVie Oral CGRP Receptor Antagonist Reaches Phase 3 Clinical End; BMS Resysitses CAR-T Cell Therapy Listing Application for Treatment of Multiple Myeloma...
CRISPR Brings A New Dawn to Treatment of Muscular Dystrophy
Time of Update: 2020-06-02
For years, scientists have been looking for a cure for muscular dystrophy In recent years, researchers have seen a new dawn in gene editing for the treatment of muscular dystrophy Recently, researcher
New lymphoma drug! Roche's first target ADC drug, poly, was approved by the European Union to treat diffuse large B cell lymphoma (DLBCL
Time of Update: 2020-01-23
January 23, 2020 / BIOON / -- Roche, a Swiss pharmaceutical giant, recently announced that the European Commission (EC) has the conditions to approve the antibody drug coupling compound (ADC) poly (po